Antibiotic spectrum index: Difference between revisions
From IDWiki
(added spectrum table) |
m (links) |
||
Line 17: | Line 17: | ||
* For each patient, the number of points for every antibiotic is added to give a total daily ASI |
* For each patient, the number of points for every antibiotic is added to give a total daily ASI |
||
== Spectrum Indices == |
== Sample Spectrum Indices == |
||
{| class="wikitable" |
{| class="wikitable sortable" |
||
!Antibiotic |
!Antibiotic |
||
!MSSA |
!MSSA |
||
Line 36: | Line 36: | ||
!ASI |
!ASI |
||
|- |
|- |
||
|Dicloxacillin |
|[[Dicloxacillin]] |
||
|1 |
|1 |
||
|0 |
|0 |
||
Line 53: | Line 53: | ||
|1 |
|1 |
||
|- |
|- |
||
|Oxacillin |
|[[Oxacillin]] |
||
|1 |
|1 |
||
|0 |
|0 |
||
Line 70: | Line 70: | ||
|1 |
|1 |
||
|- |
|- |
||
|Amoxicillin |
|[[Amoxicillin]] |
||
|0 |
|0 |
||
|1 |
|1 |
||
Line 87: | Line 87: | ||
|2 |
|2 |
||
|- |
|- |
||
|Ampicillin |
|[[Ampicillin]] |
||
|0 |
|0 |
||
|1 |
|1 |
||
Line 104: | Line 104: | ||
|2 |
|2 |
||
|- |
|- |
||
|Cephalexin |
|[[Cephalexin]] |
||
|1 |
|1 |
||
|0 |
|0 |
||
Line 121: | Line 121: | ||
|2 |
|2 |
||
|- |
|- |
||
|Erythromycin |
|[[Erythromycin]] |
||
|0 |
|0 |
||
|0 |
|0 |
||
Line 138: | Line 138: | ||
|2 |
|2 |
||
|- |
|- |
||
|Erythromycin |
|[[Erythromycin]] |
||
|0 |
|0 |
||
|0 |
|0 |
||
Line 155: | Line 155: | ||
|2 |
|2 |
||
|- |
|- |
||
|Metronidazole |
|[[Metronidazole]] |
||
|0 |
|0 |
||
|0 |
|0 |
||
Line 172: | Line 172: | ||
|2 |
|2 |
||
|- |
|- |
||
|Penicillin |
|[[Penicillin]] |
||
|0 |
|0 |
||
|1 |
|1 |
||
Line 189: | Line 189: | ||
|2 |
|2 |
||
|- |
|- |
||
|Aztreonam |
|[[Aztreonam]] |
||
|0 |
|0 |
||
|0 |
|0 |
||
Line 206: | Line 206: | ||
|3 |
|3 |
||
|- |
|- |
||
|Cefazolin |
|[[Cefazolin]] |
||
|1 |
|1 |
||
|0 |
|0 |
||
Line 223: | Line 223: | ||
|3 |
|3 |
||
|- |
|- |
||
|Cefdinir |
|[[Cefdinir]] |
||
|1 |
|1 |
||
|0 |
|0 |
||
Line 240: | Line 240: | ||
|3 |
|3 |
||
|- |
|- |
||
|Cefixime |
|[[Cefixime]] |
||
|0 |
|0 |
||
|0 |
|0 |
||
Line 257: | Line 257: | ||
|3 |
|3 |
||
|- |
|- |
||
|Cefpodoxime |
|[[Cefpodoxime]] |
||
|1 |
|1 |
||
|0 |
|0 |
||
Line 274: | Line 274: | ||
|3 |
|3 |
||
|- |
|- |
||
|Rifampin |
|[[Rifampin]] |
||
|1 |
|1 |
||
|0 |
|0 |
||
Line 291: | Line 291: | ||
|3 |
|3 |
||
|- |
|- |
||
|Azithromycin |
|[[Azithromycin]] |
||
|1 |
|1 |
||
|0 |
|0 |
||
Line 308: | Line 308: | ||
|4 |
|4 |
||
|- |
|- |
||
|Cefprozil |
|[[Cefprozil]] |
||
|1 |
|1 |
||
|0 |
|0 |
||
Line 325: | Line 325: | ||
|4 |
|4 |
||
|- |
|- |
||
|Ceftazidime |
|[[Ceftazidime]] |
||
|0 |
|0 |
||
|0 |
|0 |
||
Line 342: | Line 342: | ||
|4 |
|4 |
||
|- |
|- |
||
|Cefuroxime |
|[[Cefuroxime]] |
||
|1 |
|1 |
||
|0 |
|0 |
||
Line 359: | Line 359: | ||
|4 |
|4 |
||
|- |
|- |
||
|Chloramphenicol |
|[[Chloramphenicol]] |
||
|0 |
|0 |
||
|0 |
|0 |
||
Line 376: | Line 376: | ||
|4 |
|4 |
||
|- |
|- |
||
|Clarithromycin |
|[[Clarithromycin]] |
||
|1 |
|1 |
||
|0 |
|0 |
||
Line 393: | Line 393: | ||
|4 |
|4 |
||
|- |
|- |
||
|Clindamycin |
|[[Clindamycin]] |
||
|1 |
|1 |
||
|0 |
|0 |
||
Line 410: | Line 410: | ||
|4 |
|4 |
||
|- |
|- |
||
|Piperacillin |
|[[Piperacillin]] |
||
|0 |
|0 |
||
|1 |
|1 |
||
Line 427: | Line 427: | ||
|4 |
|4 |
||
|- |
|- |
||
|[[TMP-SMX]] |
|||
|Trimethoprim- sulfamethoxazole |
|||
|1 |
|1 |
||
|0 |
|0 |
||
Line 444: | Line 444: | ||
|4 |
|4 |
||
|- |
|- |
||
|Cefotaxime |
|[[Cefotaxime]] |
||
|1 |
|1 |
||
|0 |
|0 |
||
Line 461: | Line 461: | ||
|5 |
|5 |
||
|- |
|- |
||
|Cefoxitin |
|[[Cefoxitin]] |
||
|1 |
|1 |
||
|0 |
|0 |
||
Line 478: | Line 478: | ||
|5 |
|5 |
||
|- |
|- |
||
|Ceftriaxone |
|[[Ceftriaxone]] |
||
|1 |
|1 |
||
|0 |
|0 |
||
Line 495: | Line 495: | ||
|5 |
|5 |
||
|- |
|- |
||
|[[Colistin]] |
|||
|Colistimethate |
|||
|0 |
|0 |
||
|0 |
|0 |
||
Line 512: | Line 512: | ||
|5 |
|5 |
||
|- |
|- |
||
|Daptomycin |
|[[Daptomycin]] |
||
|1 |
|1 |
||
|1 |
|1 |
||
Line 529: | Line 529: | ||
|5 |
|5 |
||
|- |
|- |
||
|Doxycycline |
|[[Doxycycline]] |
||
|1 |
|1 |
||
|0 |
|0 |
||
Line 546: | Line 546: | ||
|5 |
|5 |
||
|- |
|- |
||
|Gentamicin |
|[[Gentamicin]] |
||
|1 |
|1 |
||
|0 |
|0 |
||
Line 563: | Line 563: | ||
|5 |
|5 |
||
|- |
|- |
||
|Minocycline |
|[[Minocycline]] |
||
|1 |
|1 |
||
|0 |
|0 |
||
Line 580: | Line 580: | ||
|5 |
|5 |
||
|- |
|- |
||
|Telavancin |
|[[Telavancin]] |
||
|1 |
|1 |
||
|1 |
|1 |
||
Line 597: | Line 597: | ||
|5 |
|5 |
||
|- |
|- |
||
|Tobramycin |
|[[Tobramycin]] |
||
|1 |
|1 |
||
|0 |
|0 |
||
Line 614: | Line 614: | ||
|5 |
|5 |
||
|- |
|- |
||
|Vancomycin |
|[[Vancomycin]] |
||
|1 |
|1 |
||
|1 |
|1 |
||
Line 631: | Line 631: | ||
|5 |
|5 |
||
|- |
|- |
||
|Amikacin |
|[[Amikacin]] |
||
|1 |
|1 |
||
|0 |
|0 |
||
Line 648: | Line 648: | ||
|6 |
|6 |
||
|- |
|- |
||
|Amoxicillin- |
|[[Amoxicillin-clavulanic acid]] |
||
|1 |
|1 |
||
|1 |
|1 |
||
Line 665: | Line 665: | ||
|6 |
|6 |
||
|- |
|- |
||
|Ampicillin-sulbactam |
|[[Ampicillin-sulbactam]] |
||
|1 |
|1 |
||
|1 |
|1 |
||
Line 682: | Line 682: | ||
|6 |
|6 |
||
|- |
|- |
||
|Cefepime |
|[[Cefepime]] |
||
|1 |
|1 |
||
|0 |
|0 |
||
Line 699: | Line 699: | ||
|6 |
|6 |
||
|- |
|- |
||
|Linezolid |
|[[Linezolid]] |
||
|1 |
|1 |
||
|1 |
|1 |
||
Line 716: | Line 716: | ||
|6 |
|6 |
||
|- |
|- |
||
|Ticarcillin-clavulanate |
|[[Ticarcillin-clavulanate]] |
||
|1 |
|1 |
||
|0 |
|0 |
||
Line 733: | Line 733: | ||
|6 |
|6 |
||
|- |
|- |
||
|Ceftaroline |
|[[Ceftaroline]] |
||
|1 |
|1 |
||
|1 |
|1 |
||
Line 750: | Line 750: | ||
|8 |
|8 |
||
|- |
|- |
||
|Ciprofloxacin |
|[[Ciprofloxacin]] |
||
|1 |
|1 |
||
|1 |
|1 |
||
Line 767: | Line 767: | ||
|8 |
|8 |
||
|- |
|- |
||
|Piperacillin-tazobactam |
|[[Piperacillin-tazobactam]] |
||
|1 |
|1 |
||
|1 |
|1 |
||
Line 784: | Line 784: | ||
|8 |
|8 |
||
|- |
|- |
||
|Ertapenem |
|[[Ertapenem]] |
||
|1 |
|1 |
||
|0 |
|0 |
||
Line 801: | Line 801: | ||
|9 |
|9 |
||
|- |
|- |
||
|Levofloxacin |
|[[Levofloxacin]] |
||
|1 |
|1 |
||
|1 |
|1 |
||
Line 818: | Line 818: | ||
|9 |
|9 |
||
|- |
|- |
||
|Meropenem |
|[[Meropenem]] |
||
|1 |
|1 |
||
|0 |
|0 |
||
Line 835: | Line 835: | ||
|10 |
|10 |
||
|- |
|- |
||
|Moxifloxacin |
|[[Moxifloxacin]] |
||
|1 |
|1 |
||
|1 |
|1 |
||
Line 852: | Line 852: | ||
|10 |
|10 |
||
|- |
|- |
||
|Imipenem-cilastatin |
|[[Imipenem-cilastatin]] |
||
|1 |
|1 |
||
|1 |
|1 |
||
Line 869: | Line 869: | ||
|11 |
|11 |
||
|- |
|- |
||
|Tigecycline |
|[[Tigecycline]] |
||
|1 |
|1 |
||
|1 |
|1 |
Revision as of 12:16, 22 September 2022
- Measures the spectrum of an antibiotic, with a range from 0 to 14
- One point for activity against each of the following:
- Methicillin-sensitive Staphylococcus aureus (MSSA)
- Methicillin-resistant Staphylococcus aureus (MRSA)
- Enterococcus faecalis
- Vancomycin-resistant Enterococcus faecalis (VRE)
- Escherichia coli or Klebsiella
- AmpC producers (Enterobacter, Serratia, and Citrobacter)
- Extended-spectrum β-lactamase (ESBL) E. coli/Klebsiella
- Pseudomonas aeruginosa
- Penicillin-resistant pneumococcus (PRP)
- Moraxella and Haemophilus influenzae
- Mycoplasma and Chlamydophila
- Anaerobes (in general)
- Bacteriodes fragilis (specifically)
- Multidrug-resistant organisms
- For each patient, the number of points for every antibiotic is added to give a total daily ASI
Sample Spectrum Indices
Antibiotic | MSSA | Enterococcus | Anaerobes | Bacteroides | Moraxella/Haemophilus | Escherichia/Klebsiella | AmpC | ESBL | Pseudomonas | MRSA | Pen-R pneumococcus | VRE | Atypical | MDRO | ASI |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dicloxacillin | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Oxacillin | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Amoxicillin | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
Ampicillin | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
Cephalexin | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
Erythromycin | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 2 |
Erythromycin | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 2 |
Metronidazole | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
Penicillin | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
Aztreonam | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 3 |
Cefazolin | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
Cefdinir | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
Cefixime | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
Cefpodoxime | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
Rifampin | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 3 |
Azithromycin | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 4 |
Cefprozil | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 |
Ceftazidime | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 4 |
Cefuroxime | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 |
Chloramphenicol | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 |
Clarithromycin | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 4 |
Clindamycin | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 4 |
Piperacillin | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 4 |
TMP-SMX | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 4 |
Cefotaxime | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 5 |
Cefoxitin | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 |
Ceftriaxone | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 5 |
Colistin | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 5 |
Daptomycin | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 5 |
Doxycycline | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 5 |
Gentamicin | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 5 |
Minocycline | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 5 |
Telavancin | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 5 |
Tobramycin | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 5 |
Vancomycin | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 5 |
Amikacin | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 6 |
Amoxicillin-clavulanic acid | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 |
Ampicillin-sulbactam | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 |
Cefepime | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 6 |
Linezolid | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 6 |
Ticarcillin-clavulanate | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6 |
Ceftaroline | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 8 |
Ciprofloxacin | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 8 |
Piperacillin-tazobactam | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 8 |
Ertapenem | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 9 |
Levofloxacin | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 9 |
Meropenem | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 10 |
Moxifloxacin | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 10 |
Imipenem-cilastatin | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 11 |
Tigecycline | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 13 |
Further Reading
- Development and Application of an Antibiotic Spectrum Index for Benchmarking Antibiotic Selection Patterns Across Hospitals. Infect Control Hosp Epidemiol. 2017;38(8):993-997. doi: 10.1017/ice.2017.94.